Scholarlink

Background <p>ICU admissions among very old patients are increasing. Invasive ventilation (IV) is common, but its benefit in patients aged ≥ 90&#xa0;years is uncertain given high mortality and ethical concerns.</p> Methods <p>This retrospective cohort study analysed all consecutive ICU patients aged ≥ 90&#xa0;years admitted between 2008 and 2023 at a tertiary care centre in Germany. Demographic, clinical, and outcome data were extracted from electronic health records. Multivariable logistic regression was used to identify predictors of hospital mortality, while Kaplan–Meier survival analysis and Cox proportional hazards regression were used to assess predictors of 1-year mortality.</p> Results <p>Of 113,950 patients, 1422 (1.25%) aged ≥ 90&#xa0;years were identified (median 92&#xa0;years, IQR 91–94; 66% female). IV was administered to 434 patients (31%), while 988 (69%) were not invasively&#xa0;ventilated. Median ICU length of stay was 1.7&#xa0;days&#xa0;(IQR 1–4) overall. Among ventilated patients, the median duration of IV was 13&#xa0;h (IQR 4–44), and 66% received IV for less than 24&#xa0;h. IV was associated with higher illness severity at admission (SOFA score 9 [IQR 7–11] vs. 2 [IQR 1–4], p &lt; 0.001), longer ICU stays (2.9&#xa0;days [IQR 1.1–7.4] vs. 1.5&#xa0;days [IQR 0.9–3.1], p &lt; 0.001), as well as higher requirement of vasopressors at admission (0.112&#xa0;µg/kg/min [IQR&#xa0;0.056–0.278] vs. 0.072&#xa0;µg/kg/min [IQR&#xa0;0.038–0.133], p &lt; 0.001) and renal replacement therapy (3.5% [n = 15] vs. 1.7% [n = 17], p = 0.042). In patients requiring IV, ICU and hospital mortality were 35.7% (n = 155) and 49.3% (n = 214) vs. 11.5% (n = 114) and 21.5% (n = 212) in non-IV patients, respectively (both p &lt; 0.001). Independent and significant predictors of hospital mortality included prolonged IV duration (&gt; 72&#xa0;h: OR 4.01), peak lactate ≥ 4&#xa0;mmol/l within 72&#xa0;h (OR 6.67), as well as elevated SOFA scores (4–7: OR 1.96, ≥ 8: OR 3.46), and CCI ≥ 3 (OR 1.74) at admission. One-year mortality risks were 73.2% (95% CI 68.5–77.3%) and 53.4% (95% CI 50.0–56.6%) for IV and no-IV patients (p &lt; 0.001), respectively.</p> Conclusions <p>In this selected cohort of ICU patients aged ≥ 90&#xa0;years, invasive ventilation–particularly beyond 72&#xa0;h–identified a subgroup with very high ICU and hospital mortality and greater illness severity. These observational data support using invasive ventilation in nonagenarians as a trigger for early, patient-centred goals-of-care discussions, rather than as evidence that ventilation itself causes excess mortality.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Invasive ventilation and mortality in critically ill nonagenarians: a retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月28日

查看全文
  • Markus Haar,
  • Fabian Gleibs,
  • Anna Carola Hertrich,
  • Jakob Müller,
  • Rikus Daniels,
  • Pauline Theile,
  • Stefan Kluge,
  • Kevin Roedl

摘要

Background

ICU admissions among very old patients are increasing. Invasive ventilation (IV) is common, but its benefit in patients aged ≥ 90 years is uncertain given high mortality and ethical concerns.

Methods

This retrospective cohort study analysed all consecutive ICU patients aged ≥ 90 years admitted between 2008 and 2023 at a tertiary care centre in Germany. Demographic, clinical, and outcome data were extracted from electronic health records. Multivariable logistic regression was used to identify predictors of hospital mortality, while Kaplan–Meier survival analysis and Cox proportional hazards regression were used to assess predictors of 1-year mortality.

Results

Of 113,950 patients, 1422 (1.25%) aged ≥ 90 years were identified (median 92 years, IQR 91–94; 66% female). IV was administered to 434 patients (31%), while 988 (69%) were not invasively ventilated. Median ICU length of stay was 1.7 days (IQR 1–4) overall. Among ventilated patients, the median duration of IV was 13 h (IQR 4–44), and 66% received IV for less than 24 h. IV was associated with higher illness severity at admission (SOFA score 9 [IQR 7–11] vs. 2 [IQR 1–4], p < 0.001), longer ICU stays (2.9 days [IQR 1.1–7.4] vs. 1.5 days [IQR 0.9–3.1], p < 0.001), as well as higher requirement of vasopressors at admission (0.112 µg/kg/min [IQR 0.056–0.278] vs. 0.072 µg/kg/min [IQR 0.038–0.133], p < 0.001) and renal replacement therapy (3.5% [n = 15] vs. 1.7% [n = 17], p = 0.042). In patients requiring IV, ICU and hospital mortality were 35.7% (n = 155) and 49.3% (n = 214) vs. 11.5% (n = 114) and 21.5% (n = 212) in non-IV patients, respectively (both p < 0.001). Independent and significant predictors of hospital mortality included prolonged IV duration (> 72 h: OR 4.01), peak lactate ≥ 4 mmol/l within 72 h (OR 6.67), as well as elevated SOFA scores (4–7: OR 1.96, ≥ 8: OR 3.46), and CCI ≥ 3 (OR 1.74) at admission. One-year mortality risks were 73.2% (95% CI 68.5–77.3%) and 53.4% (95% CI 50.0–56.6%) for IV and no-IV patients (p < 0.001), respectively.

Conclusions

In this selected cohort of ICU patients aged ≥ 90 years, invasive ventilation–particularly beyond 72 h–identified a subgroup with very high ICU and hospital mortality and greater illness severity. These observational data support using invasive ventilation in nonagenarians as a trigger for early, patient-centred goals-of-care discussions, rather than as evidence that ventilation itself causes excess mortality.